Literature DB >> 5717541

Methodological study and a recommended technique for determining the euglobulin lysis time.

R Chakrabarti, M Bielawiec, J F Evans, G R Fearnley.   

Abstract

The euglobulin lysis time, which is widely used to measure blood fibrinolytic activity, is shown to be sensitive to the temperature and pH at which the euglobulin fraction of plasma is prepared and also to the type of anticoagulant employed and buffer in which it is suspended. A standardized method for performing the test, which controls these variables and has been found to yield reproducible results, is described. Since, at present, data obtained with this test by different laboratories are, for the reasons given, rarely comparable, it is hoped that the method outlined may be considered suitable for general adoption.

Mesh:

Substances:

Year:  1968        PMID: 5717541      PMCID: PMC473941          DOI: 10.1136/jcp.21.6.698

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  An evaluation of the euglobulin method for the determination of fibrinolysis.

Authors:  E KOWALSKI; M KOPEC
Journal:  J Clin Pathol       Date:  1959-05       Impact factor: 3.411

2.  The effect of citrate on euglobulin methods of estimating fibrinolytic activity.

Authors:  M BUCKELL
Journal:  J Clin Pathol       Date:  1958-09       Impact factor: 3.411

3.  Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis.

Authors:  G R FEARNLEY; G BALMFORTH; E FEARNLEY
Journal:  Clin Sci       Date:  1957-11       Impact factor: 6.124

4.  Methods for the evaluation of human fibrinolysis; studies with two combined technics.

Authors:  K N VON KAULLA; R L SCHULTZ
Journal:  Am J Clin Pathol       Date:  1958-02       Impact factor: 2.493

5.  Observations on the inactivation of fibrinolytic activity in shed blood.

Authors:  G R FEARNLEY; R REVILL; J M TWEED
Journal:  Clin Sci       Date:  1952-08       Impact factor: 6.124

6.  Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.

Authors:  G R Fearnley; R Chakrabarti
Journal:  Lancet       Date:  1966-10-08       Impact factor: 79.321

  6 in total
  9 in total

1.  Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

2.  Discrepancies between immunological and caseinolytic plasma plasminogen assays in health and hyperfibrinolytic states.

Authors:  V Musumeci; G Leone; B Bizzi
Journal:  J Clin Pathol       Date:  1974-10       Impact factor: 3.411

3.  Inhibition of gastric plasmin activity by epsilon-aminocaproic acid.

Authors:  J M Thomson; L Turner; L Poller
Journal:  Ann R Coll Surg Engl       Date:  1973-12       Impact factor: 1.891

4.  The intestine as a source of plasminogen activator activity.

Authors:  H Gans; K Mori; R Quinlan; D Richter; B H Tan
Journal:  Ann Surg       Date:  1971-11       Impact factor: 12.969

5.  Reaction pattern to three stresses--electroplexy, surgery, and myocardial infarction--of fibrinolysis and plasma fibrinogen.

Authors:  R Chakrabarti; E D Hocking; G R Fearnley
Journal:  J Clin Pathol       Date:  1969-11       Impact factor: 3.411

6.  Epsilon-aminocaproic acid therapy in ulcerative colitis.

Authors:  R H Salter; A E Read
Journal:  Gut       Date:  1970-07       Impact factor: 23.059

7.  Intrapulmonary clotting and fibrinolysis during abdominal aortic aneurysm surgery.

Authors:  G A McLoughlin; G A Grindlinger; J Manny; C R Valeri; B Lipinski; J A Mannick; H B Hechtman
Journal:  Ann Surg       Date:  1979-11       Impact factor: 12.969

8.  Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.

Authors:  Anton Ilich; Vaibhav Kumar; Michael J Ferrara; Michael W Henderson; Denis F Noubouossie; Donald H Jenkins; Rosemary A Kozar; Myung S Park; Nigel S Key
Journal:  Thromb Res       Date:  2021-05-31       Impact factor: 10.407

9.  Derangement of protein S and C4b-binding protein levels as acquired thrombophilia in HIV-infected adult Nigerians.

Authors:  Fatai O Bello; Alani S Akanmu; Titilope A Adeyemo; Bukunmi M Idowu; Prosper Okonkwo; Phyllis J Kanki
Journal:  South Afr J HIV Med       Date:  2021-08-23       Impact factor: 2.744

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.